LFTD Partners AI Stock Analysis
Want to see LIFD full AI Analyst Report?
LFTD Partners (LIFD) AI Stock Analysis
LFTD Partners
(Other OTC:LIFD)
The overall score of 43 reflects a company in severe financial distress, which is the most significant factor. The core business is shrinking rapidly with massive losses and a collapsing equity base. A recent debt payoff from a real estate sale provides a short-term liquidity cushion, but this does not address the fundamental operational decline. Technicals suggest the stock is stabilizing after a major downtrend, but the negative valuation and lack of profitability dominate the outlook.
LFTD Partners (LIFD) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $1.63M
- Dividend Yield
- ―
- Average Volume (3M)
- 2,178
- Price to Earnings (P/E)
- -0.1
- Beta (1Y)
- 0.41
- Revenue Growth
- -15.95%
- EPS Growth
- -55834.15%
- Country
- US
- Employees
- 100
- Sector
- Consumer Defensive
- Sector Strength
- 62
- Industry
- Tobacco
LFTD Partners Business Overview & Revenue Model
Company Description
LFTD Partners Inc., operating through its subsidiary Lifted Made, specializes in the production and distribution of two distinct product lines. The first consists of psychedelic products, marketed under their Silly Shruum brand. The second encompasse...
LFTD Partners Earnings Call Summary
The earnings call presented a mixed picture with notable efforts to launch new products and reduce expenses, but these were overshadowed by significant revenue declines, operating losses, and challenges in receivables. The competitive and regulatory environment continues to pose significant challenges to LFTD Partners.
Q3-2024 Updates
Positive Updates
Negative Updates
Company Guidance
During the LFTD Partners' Q3 2024 earnings call, several key metrics and strategic initiatives were discussed to address the current challenges and future prospects of the company. The company's consolidated net sales were reported at $8.6 million, a decline of 34% compared to the previous year, attributed to regulatory challenges and increased competition in the hemp-derived cannabinoid market. Despite these headwinds, the company has been proactive in reducing payroll expenses by 8% from Q1 to Q2 and another 8% from Q2 to Q3, along with a 40% reduction in professional fees from Q1 to Q2 and a further 33% reduction from Q2 to Q3. Furthermore, the company has reduced its CapEx from $747,000 in the previous year to $310,000 year-to-date. The operating loss for the quarter was $141,000, contrasting with an operating income of $659,000 in the same quarter of the previous year. The net loss was reported at $194,000 or $0.01 per share, compared to a net income of $617,000 or $0.04 per share in Q3 2023. The company's current ratio improved to 2.64, reflecting a focus on maintaining financial stability amidst industry challenges.
LFTD Partners Financial Statement Overview
Summary
Financial performance is critically weak. Revenue is in steep decline (-12% TTM) and the company has swung from a $7.2M profit in 2022 to a $33.9M net loss TTM, driven by a collapsed gross margin of 16.3%. The balance sheet shows shareholder equity nearly wiped out ($3.7M TTM) and a -66.7% return on equity. Cash flow is fragile and volatile, with poor cash generation relative to losses.
Income Statement
18Very NegativeBalance Sheet
45NeutralCash Flow
35Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Mar 2024 | Dec 2022 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 31.09M | 36.92M | 37.33M | 51.61M | 57.42M | 31.66M |
| Gross Profit | 2.23M | 12.37M | 12.75M | 19.70M | 20.99M | 15.94M |
| EBITDA | -34.19M | 2.07M | -1.50M | 3.35M | 10.31M | 7.40M |
| Net Income | -33.87M | -24.86M | -1.86M | 2.16M | 7.20M | 5.80M |
Balance Sheet | ||||||
| Total Assets | 8.32M | 19.27M | 47.32M | 51.35M | 41.13M | 39.42M |
| Cash, Cash Equivalents and Short-Term Investments | 2.49M | 1.77M | 2.15M | 4.36M | 3.72M | 1.60M |
| Total Debt | 784.11K | 1.76M | 4.51M | 4.49M | 1.86M | 1.34M |
| Total Liabilities | 4.64M | 6.88M | 9.81M | 12.53M | 6.59M | 11.96M |
| Stockholders Equity | 3.68M | 12.63M | 37.50M | 38.82M | 34.54M | 27.46M |
Cash Flow | ||||||
| Free Cash Flow | 654.87K | 1.20T | -1.27M | -150.74K | 2.12M | 5.25M |
| Operating Cash Flow | 814.45K | 1.32T | -960.07K | 638.92K | 3.04M | 5.62M |
| Investing Cash Flow | 1.28M | -121.64B | -479.57K | -2.52M | -916.12K | -446.65K |
| Financing Cash Flow | -2.53M | -2.58T | -770.95K | 3.70M | -193.42K | -4.01M |
LFTD Partners Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For LIFD, the sentiment is Positive. The current price of 0.11 is above the 20-day moving average (MA) of 0.11, above the 50-day MA of 0.11, and below the 200-day MA of 0.18, indicating a neutral trend. The MACD of 0.00 indicates Negative momentum. The RSI at 51.84 is Neutral, neither overbought nor oversold. The STOCH value of 0.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for LIFD.
LFTD Partners Peers Comparison
Overall Rating
SNOA54Neutral
TLRY46Neutral
YCBD43Neutral- LIFD43Neutral
IMCC37Underperform
PRFX37Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 62Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |
| SNOA | 54Neutral | $5.52M | -1.20 | -36.40% | ― | 38.69% | 58.68% |
| TLRY | 46Neutral | $359.12M | -1.74 | -10.30% | ― | 15.93% | 93.85% |
| YCBD | 43Neutral | $4.19M | -1.22 | -34.25% | ― | 10.01% | 95.01% |
| LIFD | 43Neutral | $1.63M | -0.05 | -93.11% | ― | -15.95% | -55834.15% |
| IMCC | 37Underperform | $936.11K | -0.02 | 841.81% | ― | -35.33% | -127.87% |
| PRFX | 37Underperform | $2.38M | -0.07 | -72.87% | ― | ― | ― |
* Consumer Defensive Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| LIFD | Lftd Partners Inc. | 0.11 | -0.16 | -58.96% | |
| SNOA | Sonoma Pharmaceuticals, Inc. | 1.09 | -2.53 | -69.89% | |
| YCBD | Cbdmd INc | 0.37 | -0.23 | -37.67% | |
| TLRY | Tilray | 2.43 | -7.87 | -76.41% | |
| PRFX | Painreform Ltd. | 0.78 | -3.64 | -82.30% | |
| IMCC | Im Cannabis Corp | 0.57 | -29.39 | -98.10% |
LFTD Partners Corporate Events
LFTD Partners Sells Headquarters, Boosts Cash Position
PositiveOn September 29, 2026, Lifted Made completed the $1.5 million sale of its former headquarters at 5511 95th Avenue in Kenosha, Wis., its only owned real estate, and used about $841,000 of the proceeds to repay all outstanding bank debt, leaving net ca...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 14, 2026